Voloridge Investment Management’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Voloridge Investment Management’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-23,254	Closed	-$464K	–	1700
2022 Q3	$464K	Buy	+23,254	New	+$307K	﹤0.01%	1277
2021 Q4	–	Sell	-70,779	Closed	-$1.64M	–	1928
2021 Q3	$1.64M	Sell	70,779 -36,836	-34%	-$871K	0.01%	1117
2021 Q2	$2.68M	Buy	107,615 +47,713	+80%	+$1.28M	0.02%	876
2021 Q1	$1.68M	Buy	59,902 +38,658	+182%	+$1.39M	0.01%	870
2020 Q4	$741K	Buy	+21,244	New	+$925K	0.01%	1049

Voloridge Investment Management's FMTX Position: Q4 2022 in Review

Voloridge Investment Management sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 23,254 shares — an estimated $464K sold.

Voloridge Investment Management first reported a position in FMTX in Q4 2020 and held it in 5 quarters. The position peaked at $2.68M in Q2 2021. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Voloridge Investment Management reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Voloridge Investment Management sold 23,254 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $464K.
Voloridge Investment Management first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
Voloridge Investment Management's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $2.68M in Q2 2021.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Voloridge Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.